SlideShare a Scribd company logo
1 of 35
Progesterone elevation on the day of
HCG administration in ivf
Aboubakr Elnashar
Benha university Hospital
AboubakrElnashar
Outline
 INTRODUCTION
 DEFINITION
 INCIDENCE
 PATHOGENESIS
 IMPACT ON PREGNANCY OUTCOME
 PREVENTION
 SUMMARY
 RECOMMENDATION
AboubakrElnashar
INTRODUCTION
•The introduction of GnRH analogues for pituitary
suppression in ivf significantly decreased the incidence
of premature LH surge
(Smitz et al., 1992).
•However, several researchers have described a
phenomenon reported as PE
(Hofmann et al., 1993; Legro et al., 1993; Ubaldi et al., 1996a; Bosch et al., 2003).
AboubakrElnashar
PE:.
aroused interest {some authors reported decreased
IR& PR}
(Silverberg et al, 1991; Fanchin et al, 1993; Harada et al., 1995)
:Cryopreservation and ET in a subsequent cycle
(Silverberg et al., 1991; Legro et al., 1993; Silverberg et al., 1994) or
HCG administration at an earlier time, prior to PE
(Harada et al., 1996).
AboubakrElnashar
DEFINITION
•Terminology:
PL: Many authors in the past have adopted this
term for PE on the day of hCG administration
(Hofmann et al., 1996; Legro et al., 1993; Ubaldi et al., 1996; Bosch et al.,
2003).
{Excessive amount of P is produced by granulosa
cells that have started the process of luteinization}.
Aboubakr Elnashar
Use of the term ‘PL’ in the presence of normal LH
levels is not appropriate, at least when GnRHa is
used to inhibit LH surge
(Venetis et al,2007)
PE in the late follicular phase may be unrelated to
any luteinizing process attributable to effects of
follicular cells to LH
(Adonakis et al, 1998)
Aboubakr Elnashar
P level
(Most studies)
cutoff level 0.8 to 2 ng/mL.
Up to 3 ng/ml
P/E2 ratio of > 1
(Younis et al, 2001, Ou et al, 2007)
 Ovarian response, rather than the serum P only
DD between the P secretion from dysmature
follicles & physiologic secretion from multiple healthy
mature follicles.
Aboubakr Elnashar
AboubakrElnashar
 P of the day of HCG and the day after HCG
(Liu et al, 2014).
P on both days were normal: IR: 36%
PE on both days: IR: 22%: embryos should be
frozen and transfer deferred to a subsequent cycle.
INCIDENCE
Marked variation: discrepancies in:
Definition
Population characteristics
Treatment protocols.
Aboubakr Elnashar
AboubakrElnashar
PE in fresh IVF cycles
The pooled rates varied
according to
Thresholds
0.4–0.6 ng/ml: 46.7%
1.9–3.0 ng/ml: 12.3%
(Venetis et al, 2013)
Protocol
>1.5 ng/ml
Agonist: 24.1%
Antagonist: 23.0%
(Papanikolaou et al, 2012)
AboubakrElnashar
Threshold
(ng/ml)
%PE
Overall Agonist Antagonist
0.4-0.6 46.7 46.7 n.a
0.8-1.1 33.5 31.5 56.0
1.2-1.4 29.0 31.6 29.8
1.5-1.75 17.2 20.3 11.1
1.9-3.0 12.3 13.0 n.a
(Venetis et al, 2013)
PATHOGENESIS
Poorly understood
(Melo et al, 2006)
Several hypotheses
I. Elevation of follicular LH levels
 Pituitary desensitization induced by GnRHa is
incomplete: The rising E2: induce increased LH
sufficient to stimulate granulose cells to produce P
but inadequate to trigger ovulation
(Peluso, 1990; Hofmann et al, 1993, Ubaldi et al., 1995)
 long GnRHa protocol can prevent premature LH
elevation in 95–98% (Ron , 1990; Penzias et al, 1992)
 Increased LH is not the only pathogenic factor
in PL
Aboubakr Elnashar
II. Serum accumulation of HCG from HMG
(Copperman et al, 1995)
hCG is higher in women who experienced a serum
P rise, during GnRHa HMG protocol, despite pituitary
suppression with GnRHa
Use of rFSH (with negligible intrinsic LH bioactivity)
should not provoke PL
(Peluso, 1990).
Serum P rise was similar (13.4%) with the use of
HMG or rFSH
(Ubaldi et al, 1996).
HCG content of HMG is not the only cause of
serum P rise.
Aboubakr Elnashar
III. Increased LH receptor sensitivity of the
granulosa cells to FSH.
{ higher cumulative exposure to E2, in
conjunction with FSH}
(Peluso, 1990; Ubaldi et al, 1996; Filicori et al., 2002; Bosch et al., 2003;
Glamoclija et al., 2005).
Aboubakr Elnashar
IV. Poor ovarian response with increased
LH sensitivity
PL (defined by the P/E2) was more prevalent
in poor ovarian responders in long GnRHa
cycles with rFSH stimulation.
(Younis et al 2001; Ou et al, 2007)
PL is not necessarily an LH dependent event
PL is related to an adversely affected
cumulus–oocyte complex.
Increase in P in the late follicular phase is
unrelated to any luteinizing process attributable
to effects of follicular cells to LH
(Adonakis et al, 1998)
Aboubakr Elnashar
AboubakrElnashar
The origin of production of P in the early follicular
phase is adrenal which shifts toward the ovaries
prior to the ovulation.
Several factors contribute to the etiology of PE:
1. Number of multiple follicles
2. Overdose of gonadotropins
3. Poor ovarian response.
IMPACT ON IVF OUTCOME
Controversial
No effect on PR
(Howles et al., 1988; Mahadevan et al., 1988; Ben-Nun et al., 1990;
Hassiakos et al., 1990; Antoine et al., 1992; Hoffman et al. 1993, 1996;
Check et al., 1994; Givens et al., 1994; Bustillo et al., 1995; Levy et al.,
1995; Ubaldi et al., 1995; Abuzeid and Sasy, 1996; Huang et al., 1996;
Miller et al., 1996; Moffit et al., 1997; Doldi et al., 1999; Lindheim et al.,
1999; Urman et al., 1999; Martinez et al., 2004)
Aboubakr Elnashar
Deleterious effect
PR has been inversely related to serum P levels on
the day of HCG administration
(Hamori et al., 1987; Edelstein et al., 1990; Schoolcraft et al., 1991;
Silverberg et al., 1991; Kagawa et al., 1992; Mio et al., 1992; Fanchin et al.,
1993; Check et al., 1994; Givens et al., 1994; Mio and Terakawa, 1995;
Harada et al., 1995; Shulman et al., 1996; Fanchin et al.,1997; Bosch et
al., 2003; Ozcakir et al., 2004 Ou et al, 2007; )
Aboubakr Elnashar
Ovarian:
Adverse effects on oocyte maturation,
fertilization or early cleavage
(Fanchimont et al., 1989; Schoolcraft et al., 1991; Silverberg et al., 1991;
Fanchin et al., 1993, 1997).
On the other hand, poorer embryo quality
was not found
(Legro et al., 1993; Hofmann et al., 1993, 1996; Check et al., 1994;
Silverberg et al., 1994;Bustillo et al., 1995; Yovel et al., 1995; Fanchin et al.,
1996).
Aboubakr Elnashar
Endometrium:
Adverse effects on implantation& subsequent embryo
development
(Garcia et al., 1984; Forman et al., 1989; Sharma et al., 1990; Silverberg et
al., 1991; Mio et al., 1992; Burns et al., 1994; Borman et al., 2004).
Abnormally accelerated endometrial maturation:
narrows the time-frame for implantation
(Forman et al. 1989, Sharma et al. 1990; Silverberg et al. 1991)
P supplementation for LPS started on the day of
HCG: No negative impact on PR
(Howles et al., 1988; Mahadevan et al., 1988; Ben-Nun et al., 1990; Hassiakos et
al., 1990).
Aboubakr Elnashar
AboubakrElnashar
Direct evidence for an effect of PE on the
endometrium has been provided by endometrial
gene expression analysis
(Labarta et al., 2011; Li et al., 2011; Van Vaerenbergh et al., 2011).
It has been suggested that ovarian response might
be a moderating factor on the association of PE
with the probability of pregnancy
(Fanchin et al., 1997b; Xu et al., 2012),
although others have challenged this idea
(Bosch et al., 2010).
PE: lower insignificant difference in PR
(SR, Venetis et al., 2007).
PE GnRHan cycles: significantly lower PR
(SR, Kolibianakis et al.,2012).
AboubakrElnashar
SR and MA of more than 60 000 cycles
(Venetis et al, 2013)
PE on the day of hCG: significant decreased PR
after fresh ET in ovarian stimulation using GnT and
GnRH analogues for IVF.
This finding was present in all PE threshold
groups evaluated, with the exception of the lowest
PE threshold group (0.4–0.6 ng/ml).
No adverse effect of PE on PR in the frozen–
thawed and the donor/recipient cycles.
AboubakrElnashar
PE is associated with
1. Retrieval of more oocytes
2. Increased E2 levels on the day of hCG. This
was significant in all PE threshold groups with
the exception of the 1.2–1.4 ng/ml group.
3. Increase in the total amount of FSH used for
ovarian stimulation, noted in 3 out of PE
threshold groups.
No evidence that the duration of ovarian
simulation is different between women with and
those without PE
AboubakrElnashar
AboubakrElnashar
A detrimental effect of PE
0.8 to 1.1 ng/ml in the general IVF population and
in the poor responders.
1.9–3.0 ng/ml. in high responders
{increased oocyte yield might compensate for the
detrimental effect of PE on the endometrium}
PREVENTION
I. Low-dose hCG alone in the late COH stages:
(Filicori et al, 2005)
rFSH/hMG followed by low-dose hCG (200 IU/d)
alone :
Reduced rFSH/hMG consumption
ICSI outcome was comparable to traditional COH
regimens stimulated follicle growth and maturation
independent of FSH administration
Reduced number of small preovulatory follicles
More estrogenic intrafollicular environment.
No PE
Aboubakr Elnashar
II. Flexible antagonist protocol
(Lainas et al, 2005)
GnRHan was initiated according to at least one of
the following
(i) at least one follicle >14 mm
(ii)E2 >600 pg/ml
(iii)LH levels >10 IU/l.
 Antagonist initiation earlier than on stimulation
D6
 Higher PR
 Prevention of premature LH surges
 Absence of PE (normal P levels on HCG day).
AboubakrElnashar
III. Mifepristone
(Escudero et al, 2005)
:long protocol with GnRHa
Mifepristone: 40 mg daily, 50 mg progesterone were
administered IM at the time of hCG administration
{counteract residual antiprogestogenic activity of
mifepristone}.
Mifepristone is effective for the prevention of
premature LH surges and/or PE
Aboubakr Elnashar
VI. hCG injection when serum P >1.0
ng/mL ("rescued" subtle P rise).
(Harada et al, 1996)
•Serum P was determined daily or/ 12 h from D7
until the administration of hCG.
improves embryo quality
IR was significantly higher
Aboubakr Elnashar
V. Aspiration of a single leading follicle
(Barash et al, 1990)
•Single leading follicle developed, whereas the other
follicles were 6 mm smaller
Efficient method to avoid premature LH surge
enabling other follicles to develop up to the
preovulatory stage.
Aboubakr Elnashar
AboubakrElnashar
VI. use milder stimulation protocols
(Kasum et al, 2013)
AboubakrElnashar
CONCLUSION
Marked variation: discrepancies in:
Definition
Population characteristics
Treatment protocols.
A detrimental effect of PE on PR
General IVF population and poor responders:
0.8-1.1 ng/ml
High responders:
1.9–3.0 ng/ml.
Several hypotheses:
Elevation of follicular LH levels
Serum accumulation of HCG from HMG
Increased LH receptor sensitivity of the granulosa
cells to FSH
Poor ovarian response with increased LH sensitivity
Aboubakr Elnashar
For prevention:
Use of Low-dose hCG alone in the late COH stages
Flexible antagonist protocol
Use of mifepristone
hCG administration when the levels of P>1.0
ng/mL.
Aspiration of a single leading follicle
use milder stimulation protocols
Aboubakr Elnashar
Thanks
AboubakrElnashar

More Related Content

What's hot

OHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesOHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesSandro Esteves
 
GnRH Agonist in Endometriosis- An Old Good Friend
GnRH Agonist in Endometriosis- An Old Good FriendGnRH Agonist in Endometriosis- An Old Good Friend
GnRH Agonist in Endometriosis- An Old Good FriendSujoy Dasgupta
 
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiOvulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiBharati Dhorepatil
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHARPERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHARAboubakr Elnashar
 
Management of Poor Responders
Management of Poor RespondersManagement of Poor Responders
Management of Poor RespondersSandro Esteves
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
On invividualization of ovarian stimulation: the arguments in favor
On invividualization of ovarian stimulation: the arguments in favorOn invividualization of ovarian stimulation: the arguments in favor
On invividualization of ovarian stimulation: the arguments in favorSandro Esteves
 
Recent advances in stimulation protocols
Recent advances in stimulation protocolsRecent advances in stimulation protocols
Recent advances in stimulation protocolsSandro Esteves
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharAboubakr Elnashar
 
Progesterone for luteal phase support in IVF cycles
 Progesterone for luteal phase support in IVF  cycles Progesterone for luteal phase support in IVF  cycles
Progesterone for luteal phase support in IVF cyclesHesham Al-Inany
 
Luteal phase support in ivf
Luteal phase support in ivfLuteal phase support in ivf
Luteal phase support in ivfmagdy abdel
 
Luteal phase support in ART Cases Dr Sharda Jain
Luteal phase  support in ART Cases Dr Sharda Jain Luteal phase  support in ART Cases Dr Sharda Jain
Luteal phase support in ART Cases Dr Sharda Jain Lifecare Centre
 
Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Aboubakr Elnashar
 

What's hot (20)

OHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesOHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI Cycles
 
EMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROMEEMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROME
 
GnRH Agonist in Endometriosis- An Old Good Friend
GnRH Agonist in Endometriosis- An Old Good FriendGnRH Agonist in Endometriosis- An Old Good Friend
GnRH Agonist in Endometriosis- An Old Good Friend
 
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiOvulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
 
Treatment of decreased ovarian reserve
Treatment of decreased ovarian reserveTreatment of decreased ovarian reserve
Treatment of decreased ovarian reserve
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
ADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSISADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSIS
 
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHARPERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
 
EMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROME EMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROME
 
Management of Poor Responders
Management of Poor RespondersManagement of Poor Responders
Management of Poor Responders
 
Luteal phase support in ART
Luteal phase support in ARTLuteal phase support in ART
Luteal phase support in ART
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
On invividualization of ovarian stimulation: the arguments in favor
On invividualization of ovarian stimulation: the arguments in favorOn invividualization of ovarian stimulation: the arguments in favor
On invividualization of ovarian stimulation: the arguments in favor
 
Recent advances in stimulation protocols
Recent advances in stimulation protocolsRecent advances in stimulation protocols
Recent advances in stimulation protocols
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr Elnashar
 
Progesterone for luteal phase support in IVF cycles
 Progesterone for luteal phase support in IVF  cycles Progesterone for luteal phase support in IVF  cycles
Progesterone for luteal phase support in IVF cycles
 
Luteal phase support in ivf
Luteal phase support in ivfLuteal phase support in ivf
Luteal phase support in ivf
 
Luteal phase support in ART Cases Dr Sharda Jain
Luteal phase  support in ART Cases Dr Sharda Jain Luteal phase  support in ART Cases Dr Sharda Jain
Luteal phase support in ART Cases Dr Sharda Jain
 
Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016
 
Optimizing IUI Outcome
Optimizing IUI OutcomeOptimizing IUI Outcome
Optimizing IUI Outcome
 

Viewers also liked

LOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVES
LOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVESLOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVES
LOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVESAboubakr Elnashar
 
Use of N-acetyl Cysteine in ovulation induction
Use of N-acetyl Cysteine  in ovulation inductionUse of N-acetyl Cysteine  in ovulation induction
Use of N-acetyl Cysteine in ovulation inductionAboubakr Elnashar
 
Role of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disordersRole of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disordersAboubakr Elnashar
 
Ultrasonography of the ovary
Ultrasonography of the ovaryUltrasonography of the ovary
Ultrasonography of the ovaryAboubakr Elnashar
 
Therapeutic uses of Progestagen in infertility and IVF
Therapeutic uses of  Progestagen  in infertility and IVF Therapeutic uses of  Progestagen  in infertility and IVF
Therapeutic uses of Progestagen in infertility and IVF Aboubakr Elnashar
 
Use of LH in IVF and IUI
Use of LH in IVF and IUIUse of LH in IVF and IUI
Use of LH in IVF and IUISandro Esteves
 
Number of oocytes and progesterone levels in IVF: Do they matter?
Number of oocytes and progesterone levels in IVF: Do they matter?Number of oocytes and progesterone levels in IVF: Do they matter?
Number of oocytes and progesterone levels in IVF: Do they matter?Sandro Esteves
 
Golden Copy
Golden CopyGolden Copy
Golden Copykariwodo
 
The Role of Recombinant hCG in IVF
The Role of Recombinant hCG in IVFThe Role of Recombinant hCG in IVF
The Role of Recombinant hCG in IVFSandro Esteves
 
Gn rh agonist trigger in gnrh antagonist cycles
Gn rh agonist trigger in gnrh antagonist cyclesGn rh agonist trigger in gnrh antagonist cycles
Gn rh agonist trigger in gnrh antagonist cyclesIVF-Mohamed Youssef AF
 
GnRH Antagonists in Controlled Ovarian Stimulation
GnRH Antagonists in Controlled Ovarian StimulationGnRH Antagonists in Controlled Ovarian Stimulation
GnRH Antagonists in Controlled Ovarian StimulationSandro Esteves
 
Infertility Hysteroscopy
Infertility HysteroscopyInfertility Hysteroscopy
Infertility Hysteroscopyguest9dc181
 
Role of tvs in early pregnancy
Role of tvs in early pregnancyRole of tvs in early pregnancy
Role of tvs in early pregnancyPoonam Loomba
 
Gn rh analogues in gynaecology
Gn rh analogues in gynaecologyGn rh analogues in gynaecology
Gn rh analogues in gynaecologyPoonam Loomba
 

Viewers also liked (20)

Obesity and ART
Obesity and ARTObesity and ART
Obesity and ART
 
LOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVES
LOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVESLOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVES
LOW AND ULTRA LOW ESTROGEN COMBINED ORAL CONTRACEPTIVES
 
Use of N-acetyl Cysteine in ovulation induction
Use of N-acetyl Cysteine  in ovulation inductionUse of N-acetyl Cysteine  in ovulation induction
Use of N-acetyl Cysteine in ovulation induction
 
Bacterial vaginosis
Bacterial vaginosisBacterial vaginosis
Bacterial vaginosis
 
INCONTINENCE OF URINE
INCONTINENCE  OF URINEINCONTINENCE  OF URINE
INCONTINENCE OF URINE
 
Role of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disordersRole of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disorders
 
Assessment of ovulation
Assessment of ovulation Assessment of ovulation
Assessment of ovulation
 
Ultrasonography of the ovary
Ultrasonography of the ovaryUltrasonography of the ovary
Ultrasonography of the ovary
 
Therapeutic uses of Progestagen in infertility and IVF
Therapeutic uses of  Progestagen  in infertility and IVF Therapeutic uses of  Progestagen  in infertility and IVF
Therapeutic uses of Progestagen in infertility and IVF
 
Brucellosis and pregnancy
Brucellosis and pregnancyBrucellosis and pregnancy
Brucellosis and pregnancy
 
Use of LH in IVF and IUI
Use of LH in IVF and IUIUse of LH in IVF and IUI
Use of LH in IVF and IUI
 
Number of oocytes and progesterone levels in IVF: Do they matter?
Number of oocytes and progesterone levels in IVF: Do they matter?Number of oocytes and progesterone levels in IVF: Do they matter?
Number of oocytes and progesterone levels in IVF: Do they matter?
 
Golden Copy
Golden CopyGolden Copy
Golden Copy
 
The Role of Recombinant hCG in IVF
The Role of Recombinant hCG in IVFThe Role of Recombinant hCG in IVF
The Role of Recombinant hCG in IVF
 
Gn rh agonist trigger in gnrh antagonist cycles
Gn rh agonist trigger in gnrh antagonist cyclesGn rh agonist trigger in gnrh antagonist cycles
Gn rh agonist trigger in gnrh antagonist cycles
 
GnRH Antagonists in Controlled Ovarian Stimulation
GnRH Antagonists in Controlled Ovarian StimulationGnRH Antagonists in Controlled Ovarian Stimulation
GnRH Antagonists in Controlled Ovarian Stimulation
 
Role of tvs in art
Role of tvs in artRole of tvs in art
Role of tvs in art
 
Infertility Hysteroscopy
Infertility HysteroscopyInfertility Hysteroscopy
Infertility Hysteroscopy
 
Role of tvs in early pregnancy
Role of tvs in early pregnancyRole of tvs in early pregnancy
Role of tvs in early pregnancy
 
Gn rh analogues in gynaecology
Gn rh analogues in gynaecologyGn rh analogues in gynaecology
Gn rh analogues in gynaecology
 

Similar to Progesterone elevation on the day of HCG administration in ivf

CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFCURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFAboubakr Elnashar
 
Obesity, SLE, Thyroid disease and ICSI
Obesity, SLE, Thyroid  disease   and ICSIObesity, SLE, Thyroid  disease   and ICSI
Obesity, SLE, Thyroid disease and ICSIAboubakr Elnashar
 
L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013t7260678
 
L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)t7260678
 
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi AjayiFinal Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayiabayomi ajayi
 
L2 alviggi key slides (1)
L2 alviggi key slides (1)L2 alviggi key slides (1)
L2 alviggi key slides (1)t7260678
 
L2 alviggi key slides
L2 alviggi key slidesL2 alviggi key slides
L2 alviggi key slidest7260678
 
Luteal Phase Support: Key Variables to Achieve Success in ART
Luteal Phase Support: Key Variables to Achieve Success in ARTLuteal Phase Support: Key Variables to Achieve Success in ART
Luteal Phase Support: Key Variables to Achieve Success in ARTSandro Esteves
 
Gonadotropins.pptx
Gonadotropins.pptxGonadotropins.pptx
Gonadotropins.pptxRaju Nair
 
Gonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulationGonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulationAboubakr Elnashar
 
Ovarian waves and random ovarian stimulation
Ovarian waves and random ovarian stimulationOvarian waves and random ovarian stimulation
Ovarian waves and random ovarian stimulationmohamedbehery2
 
what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?Aboubakr Elnashar
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success Aboubakr Elnashar
 
Clomiphene citrate adjunctives & alternatives
Clomiphene citrate  adjunctives & alternatives Clomiphene citrate  adjunctives & alternatives
Clomiphene citrate adjunctives & alternatives Aboubakr Elnashar
 
Unexplained Infertility (1)
Unexplained Infertility (1)Unexplained Infertility (1)
Unexplained Infertility (1)guest7f0a3a
 
Unexplained Infertility
Unexplained InfertilityUnexplained Infertility
Unexplained Infertilityguest7f0a3a
 
Unexplained Infertility
Unexplained InfertilityUnexplained Infertility
Unexplained Infertilityguest7f0a3a
 

Similar to Progesterone elevation on the day of HCG administration in ivf (20)

An OHSS – Free Clinic
An OHSS – Free Clinic An OHSS – Free Clinic
An OHSS – Free Clinic
 
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFCURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
 
Obesity, SLE, Thyroid disease and ICSI
Obesity, SLE, Thyroid  disease   and ICSIObesity, SLE, Thyroid  disease   and ICSI
Obesity, SLE, Thyroid disease and ICSI
 
L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013
 
L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)
 
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi AjayiFinal Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
 
L2 alviggi key slides (1)
L2 alviggi key slides (1)L2 alviggi key slides (1)
L2 alviggi key slides (1)
 
L2 alviggi key slides
L2 alviggi key slidesL2 alviggi key slides
L2 alviggi key slides
 
GnRH Agonist Versus GnRH Antagonist
GnRH Agonist Versus GnRH AntagonistGnRH Agonist Versus GnRH Antagonist
GnRH Agonist Versus GnRH Antagonist
 
Luteal Phase Support: Key Variables to Achieve Success in ART
Luteal Phase Support: Key Variables to Achieve Success in ARTLuteal Phase Support: Key Variables to Achieve Success in ART
Luteal Phase Support: Key Variables to Achieve Success in ART
 
Gonadotropins.pptx
Gonadotropins.pptxGonadotropins.pptx
Gonadotropins.pptx
 
Gonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulationGonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulation
 
Ovarian waves and random ovarian stimulation
Ovarian waves and random ovarian stimulationOvarian waves and random ovarian stimulation
Ovarian waves and random ovarian stimulation
 
what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?
 
Luteal Phase Support In IVF
Luteal Phase Support In IVFLuteal Phase Support In IVF
Luteal Phase Support In IVF
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success
 
Clomiphene citrate adjunctives & alternatives
Clomiphene citrate  adjunctives & alternatives Clomiphene citrate  adjunctives & alternatives
Clomiphene citrate adjunctives & alternatives
 
Unexplained Infertility (1)
Unexplained Infertility (1)Unexplained Infertility (1)
Unexplained Infertility (1)
 
Unexplained Infertility
Unexplained InfertilityUnexplained Infertility
Unexplained Infertility
 
Unexplained Infertility
Unexplained InfertilityUnexplained Infertility
Unexplained Infertility
 

More from Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTAboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversyAboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gynAboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineAboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021 Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown locationAboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
 

Recently uploaded

Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Call Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service ChennaiCall Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service ChennaiNehru place Escorts
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
Call Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service ChennaiCall Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service ChennaiNehru place Escorts
 
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...Nehru place Escorts
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000aliya bhat
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Serviceparulsinha
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Nehru place Escorts
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Miss joya
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...narwatsonia7
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceMiss joya
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 

Recently uploaded (20)

Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Call Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service ChennaiCall Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
Call Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service ChennaiCall Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
 
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
 
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 

Progesterone elevation on the day of HCG administration in ivf

  • 1. Progesterone elevation on the day of HCG administration in ivf Aboubakr Elnashar Benha university Hospital AboubakrElnashar
  • 2. Outline  INTRODUCTION  DEFINITION  INCIDENCE  PATHOGENESIS  IMPACT ON PREGNANCY OUTCOME  PREVENTION  SUMMARY  RECOMMENDATION AboubakrElnashar
  • 3. INTRODUCTION •The introduction of GnRH analogues for pituitary suppression in ivf significantly decreased the incidence of premature LH surge (Smitz et al., 1992). •However, several researchers have described a phenomenon reported as PE (Hofmann et al., 1993; Legro et al., 1993; Ubaldi et al., 1996a; Bosch et al., 2003). AboubakrElnashar
  • 4. PE:. aroused interest {some authors reported decreased IR& PR} (Silverberg et al, 1991; Fanchin et al, 1993; Harada et al., 1995) :Cryopreservation and ET in a subsequent cycle (Silverberg et al., 1991; Legro et al., 1993; Silverberg et al., 1994) or HCG administration at an earlier time, prior to PE (Harada et al., 1996). AboubakrElnashar
  • 5. DEFINITION •Terminology: PL: Many authors in the past have adopted this term for PE on the day of hCG administration (Hofmann et al., 1996; Legro et al., 1993; Ubaldi et al., 1996; Bosch et al., 2003). {Excessive amount of P is produced by granulosa cells that have started the process of luteinization}. Aboubakr Elnashar
  • 6. Use of the term ‘PL’ in the presence of normal LH levels is not appropriate, at least when GnRHa is used to inhibit LH surge (Venetis et al,2007) PE in the late follicular phase may be unrelated to any luteinizing process attributable to effects of follicular cells to LH (Adonakis et al, 1998) Aboubakr Elnashar
  • 7. P level (Most studies) cutoff level 0.8 to 2 ng/mL. Up to 3 ng/ml P/E2 ratio of > 1 (Younis et al, 2001, Ou et al, 2007)  Ovarian response, rather than the serum P only DD between the P secretion from dysmature follicles & physiologic secretion from multiple healthy mature follicles. Aboubakr Elnashar
  • 8. AboubakrElnashar  P of the day of HCG and the day after HCG (Liu et al, 2014). P on both days were normal: IR: 36% PE on both days: IR: 22%: embryos should be frozen and transfer deferred to a subsequent cycle.
  • 9. INCIDENCE Marked variation: discrepancies in: Definition Population characteristics Treatment protocols. Aboubakr Elnashar
  • 10. AboubakrElnashar PE in fresh IVF cycles The pooled rates varied according to Thresholds 0.4–0.6 ng/ml: 46.7% 1.9–3.0 ng/ml: 12.3% (Venetis et al, 2013) Protocol >1.5 ng/ml Agonist: 24.1% Antagonist: 23.0% (Papanikolaou et al, 2012)
  • 11. AboubakrElnashar Threshold (ng/ml) %PE Overall Agonist Antagonist 0.4-0.6 46.7 46.7 n.a 0.8-1.1 33.5 31.5 56.0 1.2-1.4 29.0 31.6 29.8 1.5-1.75 17.2 20.3 11.1 1.9-3.0 12.3 13.0 n.a (Venetis et al, 2013)
  • 12. PATHOGENESIS Poorly understood (Melo et al, 2006) Several hypotheses I. Elevation of follicular LH levels  Pituitary desensitization induced by GnRHa is incomplete: The rising E2: induce increased LH sufficient to stimulate granulose cells to produce P but inadequate to trigger ovulation (Peluso, 1990; Hofmann et al, 1993, Ubaldi et al., 1995)  long GnRHa protocol can prevent premature LH elevation in 95–98% (Ron , 1990; Penzias et al, 1992)  Increased LH is not the only pathogenic factor in PL Aboubakr Elnashar
  • 13. II. Serum accumulation of HCG from HMG (Copperman et al, 1995) hCG is higher in women who experienced a serum P rise, during GnRHa HMG protocol, despite pituitary suppression with GnRHa Use of rFSH (with negligible intrinsic LH bioactivity) should not provoke PL (Peluso, 1990). Serum P rise was similar (13.4%) with the use of HMG or rFSH (Ubaldi et al, 1996). HCG content of HMG is not the only cause of serum P rise. Aboubakr Elnashar
  • 14. III. Increased LH receptor sensitivity of the granulosa cells to FSH. { higher cumulative exposure to E2, in conjunction with FSH} (Peluso, 1990; Ubaldi et al, 1996; Filicori et al., 2002; Bosch et al., 2003; Glamoclija et al., 2005). Aboubakr Elnashar
  • 15. IV. Poor ovarian response with increased LH sensitivity PL (defined by the P/E2) was more prevalent in poor ovarian responders in long GnRHa cycles with rFSH stimulation. (Younis et al 2001; Ou et al, 2007) PL is not necessarily an LH dependent event PL is related to an adversely affected cumulus–oocyte complex. Increase in P in the late follicular phase is unrelated to any luteinizing process attributable to effects of follicular cells to LH (Adonakis et al, 1998) Aboubakr Elnashar
  • 16. AboubakrElnashar The origin of production of P in the early follicular phase is adrenal which shifts toward the ovaries prior to the ovulation. Several factors contribute to the etiology of PE: 1. Number of multiple follicles 2. Overdose of gonadotropins 3. Poor ovarian response.
  • 17. IMPACT ON IVF OUTCOME Controversial No effect on PR (Howles et al., 1988; Mahadevan et al., 1988; Ben-Nun et al., 1990; Hassiakos et al., 1990; Antoine et al., 1992; Hoffman et al. 1993, 1996; Check et al., 1994; Givens et al., 1994; Bustillo et al., 1995; Levy et al., 1995; Ubaldi et al., 1995; Abuzeid and Sasy, 1996; Huang et al., 1996; Miller et al., 1996; Moffit et al., 1997; Doldi et al., 1999; Lindheim et al., 1999; Urman et al., 1999; Martinez et al., 2004) Aboubakr Elnashar
  • 18. Deleterious effect PR has been inversely related to serum P levels on the day of HCG administration (Hamori et al., 1987; Edelstein et al., 1990; Schoolcraft et al., 1991; Silverberg et al., 1991; Kagawa et al., 1992; Mio et al., 1992; Fanchin et al., 1993; Check et al., 1994; Givens et al., 1994; Mio and Terakawa, 1995; Harada et al., 1995; Shulman et al., 1996; Fanchin et al.,1997; Bosch et al., 2003; Ozcakir et al., 2004 Ou et al, 2007; ) Aboubakr Elnashar
  • 19. Ovarian: Adverse effects on oocyte maturation, fertilization or early cleavage (Fanchimont et al., 1989; Schoolcraft et al., 1991; Silverberg et al., 1991; Fanchin et al., 1993, 1997). On the other hand, poorer embryo quality was not found (Legro et al., 1993; Hofmann et al., 1993, 1996; Check et al., 1994; Silverberg et al., 1994;Bustillo et al., 1995; Yovel et al., 1995; Fanchin et al., 1996). Aboubakr Elnashar
  • 20. Endometrium: Adverse effects on implantation& subsequent embryo development (Garcia et al., 1984; Forman et al., 1989; Sharma et al., 1990; Silverberg et al., 1991; Mio et al., 1992; Burns et al., 1994; Borman et al., 2004). Abnormally accelerated endometrial maturation: narrows the time-frame for implantation (Forman et al. 1989, Sharma et al. 1990; Silverberg et al. 1991) P supplementation for LPS started on the day of HCG: No negative impact on PR (Howles et al., 1988; Mahadevan et al., 1988; Ben-Nun et al., 1990; Hassiakos et al., 1990). Aboubakr Elnashar
  • 21. AboubakrElnashar Direct evidence for an effect of PE on the endometrium has been provided by endometrial gene expression analysis (Labarta et al., 2011; Li et al., 2011; Van Vaerenbergh et al., 2011). It has been suggested that ovarian response might be a moderating factor on the association of PE with the probability of pregnancy (Fanchin et al., 1997b; Xu et al., 2012), although others have challenged this idea (Bosch et al., 2010).
  • 22. PE: lower insignificant difference in PR (SR, Venetis et al., 2007). PE GnRHan cycles: significantly lower PR (SR, Kolibianakis et al.,2012). AboubakrElnashar
  • 23. SR and MA of more than 60 000 cycles (Venetis et al, 2013) PE on the day of hCG: significant decreased PR after fresh ET in ovarian stimulation using GnT and GnRH analogues for IVF. This finding was present in all PE threshold groups evaluated, with the exception of the lowest PE threshold group (0.4–0.6 ng/ml). No adverse effect of PE on PR in the frozen– thawed and the donor/recipient cycles. AboubakrElnashar
  • 24. PE is associated with 1. Retrieval of more oocytes 2. Increased E2 levels on the day of hCG. This was significant in all PE threshold groups with the exception of the 1.2–1.4 ng/ml group. 3. Increase in the total amount of FSH used for ovarian stimulation, noted in 3 out of PE threshold groups. No evidence that the duration of ovarian simulation is different between women with and those without PE AboubakrElnashar
  • 25. AboubakrElnashar A detrimental effect of PE 0.8 to 1.1 ng/ml in the general IVF population and in the poor responders. 1.9–3.0 ng/ml. in high responders {increased oocyte yield might compensate for the detrimental effect of PE on the endometrium}
  • 26. PREVENTION I. Low-dose hCG alone in the late COH stages: (Filicori et al, 2005) rFSH/hMG followed by low-dose hCG (200 IU/d) alone : Reduced rFSH/hMG consumption ICSI outcome was comparable to traditional COH regimens stimulated follicle growth and maturation independent of FSH administration Reduced number of small preovulatory follicles More estrogenic intrafollicular environment. No PE Aboubakr Elnashar
  • 27. II. Flexible antagonist protocol (Lainas et al, 2005) GnRHan was initiated according to at least one of the following (i) at least one follicle >14 mm (ii)E2 >600 pg/ml (iii)LH levels >10 IU/l.  Antagonist initiation earlier than on stimulation D6  Higher PR  Prevention of premature LH surges  Absence of PE (normal P levels on HCG day). AboubakrElnashar
  • 28. III. Mifepristone (Escudero et al, 2005) :long protocol with GnRHa Mifepristone: 40 mg daily, 50 mg progesterone were administered IM at the time of hCG administration {counteract residual antiprogestogenic activity of mifepristone}. Mifepristone is effective for the prevention of premature LH surges and/or PE Aboubakr Elnashar
  • 29. VI. hCG injection when serum P >1.0 ng/mL ("rescued" subtle P rise). (Harada et al, 1996) •Serum P was determined daily or/ 12 h from D7 until the administration of hCG. improves embryo quality IR was significantly higher Aboubakr Elnashar
  • 30. V. Aspiration of a single leading follicle (Barash et al, 1990) •Single leading follicle developed, whereas the other follicles were 6 mm smaller Efficient method to avoid premature LH surge enabling other follicles to develop up to the preovulatory stage. Aboubakr Elnashar
  • 31. AboubakrElnashar VI. use milder stimulation protocols (Kasum et al, 2013)
  • 32. AboubakrElnashar CONCLUSION Marked variation: discrepancies in: Definition Population characteristics Treatment protocols. A detrimental effect of PE on PR General IVF population and poor responders: 0.8-1.1 ng/ml High responders: 1.9–3.0 ng/ml.
  • 33. Several hypotheses: Elevation of follicular LH levels Serum accumulation of HCG from HMG Increased LH receptor sensitivity of the granulosa cells to FSH Poor ovarian response with increased LH sensitivity Aboubakr Elnashar
  • 34. For prevention: Use of Low-dose hCG alone in the late COH stages Flexible antagonist protocol Use of mifepristone hCG administration when the levels of P>1.0 ng/mL. Aspiration of a single leading follicle use milder stimulation protocols Aboubakr Elnashar